Trusted brands in one place
Clinically proven for weight loss
Doctor-guided programs
No in-person appointments needed
Trusted brands in one place
Clinically proven for weight loss
Doctor-guided programs
No in-person appointments needed

Explore GLP-1's
News & Updates

Learn more about GLP'-1's latest news & updates

Explore By Category

All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Oral Wegovy vs. Mounjaro: What It Means for You
Drug Comparisons

Oral Wegovy vs. Mounjaro: What It Means for You

Novo Nordisk's oral semaglutide (oral Wegovy) is entering the market and putting pressure on Eli Lilly's dominance in the GLP-1 space. For patients, more competition could mean more choices, better pricing, and new questions to ask your doctor. Here's what you need to know.

Read More
Wegovy Pill vs. Foundayo Pill: GLP-1 Comparison
Drug Comparisons

Wegovy Pill vs. Foundayo Pill: GLP-1 Comparison

Two new oral GLP-1 medications are entering the market, and understanding how they differ could shape your weight loss plan. This guide breaks down the Wegovy pill and Foundayo pill side by side, covering how each works, what the clinical data shows, and what to ask your doctor before choosing one.

Read More
Novo Nordisk's Lower-Cost Ozempic: What It Means
News & Updates

Novo Nordisk's Lower-Cost Ozempic: What It Means

Novo Nordisk is preparing to launch a lower-cost version of Ozempic in South Africa, signaling a potential shift in how the company prices semaglutide across different markets. For patients in the U.S. and elsewhere who struggle with GLP-1 medication costs, this move raises important questions about global pricing fairness and what alternatives exist today.

Read More
Compounders Still Dominate the GLP-1 Market
News & Updates

Compounders Still Dominate the GLP-1 Market

Compounding pharmacies continue to supply a significant portion of GLP-1 medications in the U.S., even as brand-name drugs like Ozempic and Wegovy return to shelves. This article breaks down what that market reality means for patients weighing cost, access, and safety when choosing between compounded and brand-name options.

Read More
India Approves Wegovy for Fatty Liver Disease
News & Updates

India Approves Wegovy for Fatty Liver Disease

India has approved Wegovy for the treatment of fatty liver disease, marking a significant expansion of semaglutide's approved uses. This follows growing clinical evidence that GLP-1 medications can reduce liver fat and inflammation. Here's what patients need to know.

Read More
Compounded GLP-1s: FDA Crackdown Explained

Compounded GLP-1s: FDA Crackdown Explained

The FDA has taken action to restrict compounded versions of popular GLP-1 medications like semaglutide and tirzepatide. If you rely on compounded GLP-1s for weight loss, this shift affects your access, costs, and treatment options. Here's what you need to know right now.

Read More
India's Ozempic Generic Coming to South Africa
News & Updates

India's Ozempic Generic Coming to South Africa

An Indian pharmaceutical company is preparing to launch a generic version of semaglutide, the active ingredient in Ozempic, in South Africa. This could mark a turning point for GLP-1 access in emerging markets. Here is what patients and providers should understand about what is coming.

Read More
BI 3034701: Triple Receptor Obesity Drug Enters Phase II
News & Updates

BI 3034701: Triple Receptor Obesity Drug Enters Phase II

Boehringer Ingelheim has moved its investigational triple receptor agonist BI 3034701 into Phase II clinical trials, targeting GLP-1, GIP, and NPY2 receptors simultaneously. This makes it a potential first-in-class treatment that goes beyond current dual-receptor drugs like tirzepatide. Here's what patients should know about this development and what it means for the future of obesity treatment.

Read More
GLP-1 Drugs and Plastic Surgery: What to Know
Health and Wellness

GLP-1 Drugs and Plastic Surgery: What to Know

Significant weight loss from GLP-1 medications like Ozempic and Wegovy is keeping plastic surgeons busier than ever. But before you consider body contouring, there are key questions every patient should ask about timing, safety, and cost. This guide walks you through what to expect.

Read More